WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

	U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Miss
	Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the impacts of the phase I U.S.-China trade deal on Chine... (1/2/2020)

US, China Sign Phase One Trade Deal: How to Read the Agreement (1/17/2020)

Drugmakers Brace for China's Biggest-Ever Round of Price Cuts (1/16/2020)

Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigene's Mab Approval (1/6/2020) (free)

Chinese Scientist Extradited to Stand Trial in the US for Plot to Steal GSK Trade Secrets (1/6/2020)

Meeting Clinical Trial Data Requirements In Asian Markets (1/3/2020)

U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Miss (1/2/2020)

Recent Announcement for A More Effective Intellectual Property Protection System in China (12/19/2019)

Takeda Aspires to Become A Top Ten MNC Pharma Co. in China (12/18/2019)

A Few Details on the US-China "Phase One" Trade Deal (12/16/2019)

The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusions, and a Bilateral Investment Treaty (12/16/2019)

Here's What's In, What's Out of U.S.-China Trade Deal (12/13/2019)

Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Punch - With Imfinzi Lung Cancer Nod (12/12/2019)

China's Cancer Patients Hit by New Law on Experimental Drug Treatments Not Approved by Government (12/11/2019)

China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Firms (12/10/2019)

Yaobili Set to Change China's Pharmaceutical Industry with New Model (12/4/2019)


	I-Mab Biopharma Nabs $104M from Nasdaq I... (1/17/2020)
	Hengrui's Billionaire Founder Retires in... (1/17/2020)
	Round 2 of the National Level Centralize... (1/17/2020)
	Chinese Pharmaceutical Industry Growth C... (1/17/2020)
	Chinese Birthrate Falls To Lowest Level ... (1/17/2020)
	Celltrion to Build Biosimilar Plant in C... (1/16/2020)
	Innovent and Coherus Strike Licensing Ag... (1/16/2020)
	Wuxi Biologics Strikes Deal to Take Over... (1/16/2020)
	U.S.-China Phase 1 Deal Hands Pharma MNC... (1/16/2020)
	China Issues Notice for Implementing Nat... (1/16/2020)
	Review of Chinese Drug Registration Appl... (1/15/2020)
	MNC New Product Launches in China Down S... (1/15/2020)
	National Healthcare Security Working Con... (1/15/2020)
	NHC Solicits Comments on the Interim Rul... (1/15/2020)
	GenScript and Genopis Partner to Manufac... (1/15/2020)

	Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
	PhRMA Calls for Trade Deals That Force Countries to Pay ...
	IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
	Pfizer and GSK Announce JV to Create a Global Consumer H...
	Top 25 Global Pharmaceutical Companies by Market Cap 201...

	PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
	Chinese Cancer Drug Market to Surpass $30+ Billion by 2025
	NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
	IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
	IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019

	I-Mab Biopharma Nabs $104M from Nasdaq IPO
	Chinese Pharmaceutical Industry Growth Continued to Slow in ...
	Celltrion to Build Biosimilar Plant in China
	Innovent and Coherus Strike Licensing Agreement for Avastin ...
	Wuxi Biologics Strikes Deal to Take Over A Bayer Plant in Ge...

	Review of Chinese Drug Registration Applications and App...
	NMPA Issues Notice on Matters Relating to API Registrati...
	NMPA Publicizes List of Reference Formulations for Gener...
	NMPA Publicizes List of Reference Formulations for Gener...
	NMPA Deputy Commissioner Meets with PMDA Chief Executive...

	U.S.-China Phase 1 Deal Hands Pharma MNCs A Major IPR Win
	US, China Agree To Protect Patents, Fight Trade Secret Abuse...
	China Jails Three Researchers Involved in Gene-edited Babies...
	China Adopts New Law to Promote Basic Medical and Health Car...
	Chinese Medical Researcher Investigated for Smuggling Vials ...

	Nikkei: Japan's Generic Drugmakers Have A China Dependen...
	Korea's Growing Reliance on China for API Supply Flagged...
	WuXi STA's Jinshan Facility Passes EMA Inspection
	Novartis Disposes Suzhou Novartis PharmTech in Changshu ...
	FDA Warns Chinese API Producer Yino

	Ambrx and Sino Biopharma Announce Collaboration to Devel...
	Chi-Med Initiates a PII Trial of Surufatinib in Combo wi...
	NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Bio...
	HK Researcher Discovers Anticancer NCE Phorbiplatin
	Innovent and Sirnaomics Cooperate to Combine Sintilimab ...

	Round 2 of the National Level Centralized Drug Purchase ...
	Chinese Birthrate Falls To Lowest Level In 70 Years
	China Issues Notice for Implementing National Level Cent...
	National Healthcare Security Working Conference Lays Out...
	NHC Solicits Comments on the Interim Rules for National ...

	Hengrui's Billionaire Founder Retires into the Backseat
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves

	U.S. and China Inks Phase One Trade Deal
	Amid Trade War, China Lowers Import Tariffs on 850 Produ...
	Upcoming Event: International Conference on Biosimilars ...
	Upcoming Event: Biologics Manufacturing Asia 2020
	Upcoming Event: Asia Wellness Expo 2020

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

WiCON Publishes the China Phar...

WiCON to Hold Pharma China Ann...

WiCON Publishes the China Phar...

WiCON Officially Publishes Chi...

Site map | Contact Us | Links